Dynamics of brain iron levels in multiple sclerosis A longitudinal 3T MRI study

Neurology

Volumn 84, Issue 24, 2015, Pages 2396-2402

  Khalil, Michael ^a   Langkammer, Christian ^a   Pichler, Alexander ^a   Pinter, Daniela ^a   Gattringer, Thomas ^a   Bachmaier, Gerhard ^b   Ropele, Stefan ^a   Fuchs, Siegrid ^a   Enzinger, Christian ^a   Fazekas, Franz ^a  

^a Division of Neuroradiology   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; ARTICLE; BASAL GANGLION; BRAIN LEVEL; CAUDATE NUCLEUS; CONTROLLED STUDY; DEMOGRAPHY; DEMYELINATING DISEASE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PUTAMEN; THALAMUS; BRAIN; COMPARATIVE STUDY; DISABILITY; DISEASE COURSE; METABOLISM; ORGAN SIZE; PATHOLOGY;

ADULT; BRAIN; DEMYELINATING DISEASES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GRAY MATTER; HUMANS; IRON; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; ORGAN SIZE;

EID: 84931040542     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001679     Document Type: Article

References (34)

1. Ropele S, de Graaf W, Khalil M, et al. MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 2011;34:13-21.
2. Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 2007;4:371-386.
3. Stankiewicz JM, Neema M, Ceccarelli A. Iron and multiple sclerosis. Neurobiol Aging 2014;35:S51-S58.
4. Khalil M, Enzinger C, Langkammer C, et al. Quantitative assessment of brain iron by R(2)∗ relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009;15:1048-1054.
5. Khalil M, Langkammer C, Ropele S, et al. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77:1691-1697.
6. Rovira A, Montalban X. MR brain iron mapping in MS: a potential neurodegenerative marker or just another technique? Neurology 2011;77:1660-1661.
7. Walsh AJ, Blevins G, Lebel RM, Seres P, Emery DJ, Wilman AH. Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology 2014;270:186-196.
8. Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009;2:2.
9. Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci 2013;14:551-564.
10. Stephenson E, Nathoo N, Mahjoub Y, Dunn JF, Yong VW. Iron in multiple sclerosis: roles in neurodegen-eration and repair. Nat Rev Neurol 2014;10:459-468.
11. Hametner S, Wimmer I, Haider L, Pfeifenbring S, Brück W, Lassmann H. Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 2013;74:848-861.
12. Ropele S, Wattjes MP, Langkammer C, et al. Multicenter R2∗ mapping in the healthy brain. Magn Reson Med Epub 2013 May 8.
13. Langkammer C, Liu T, Khalil M, et al. Quantitative susceptibility mapping in multiple sclerosis. Radiology 2013;267:551-559.
14. Walsh AJ, Lebel RM, Eissa A, et al. Multiple sclerosis: validation of MR imaging for quantification and detection of iron. Radiology 2013;267:531-542.
15. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008;14:1157-1174.
16. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
18. He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2∗ measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification. Magn Reson Med 2008;60:1082-1089.
19. Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907-922.
20. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23:S208-S219.
21. Plummer D. DISPImage: a display and analysis tool for medical images. Rev Neuroradiol 1992;5:489-495.
22. Khalil M, Enzinger C, Langkammer C, et al. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler 2011; 17:173-180.
23. Enzinger C, Ropele S, Smith S, et al. Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4. Ann Neurol 2004;55:563-569.
24. Ropele S, Kilsdonk ID, Wattjes MP, et al. Determinants of iron accumulation in deep grey matter of multiple sclerosis patients. Mult Scler Epub 2014 Apr 30.
25. Bermel RA, Puli SR, Rudick RA, et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005;62:1371-1376.
26. Roxburgh RH, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005;64: 1144-1151.
27. Mehta V, Pei W, Yang G, et al. Iron is a sensitive bio-marker for inflammation in multiple sclerosis lesions. PLoS One 2013;8:e57573.
28. Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397-399.
29. Weigel KJ, Lynch SG, Levine SM. Iron chelation and multiple sclerosis. ASN Neuro 2014;6:e00136.
30. Williams R, Buchheit CL, Berman NEJ, LeVine SM. Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 2012;120:7-25.
31. Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 1988;51:260-265.
32. Bagnato F, Hametner S, Yao B, et al. Tracking iron in multiple sclerosis: a combined imaging and histopatholog-ical study at 7 Tesla. Brain 2011;134:3602-3615.
33. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3: 41-51.
34. Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010;257:455-462.